MISSISSAUGA, ON, Aug. 8, 2024 /CNW/ -- Abbott (NYSE: ABT) today announced that the Government of Quebec's Régie de l'assurance maladie du Québec (RAMQ) published an update to its formulary that includes expanded reimbursement for Abbott's FreeStyle Libre 2* flash glucose monitoring system to more adults living with type 1 and type 2 diabetes.
Read more at newswire.caQuebec Expands Public Reimbursement of Abbott's FreeStyle Libre® 2 Flash Glucose Monitoring System to More Adults with Diabetes
Provided Content: Content provided by Newswire.ca. The Globe and Mail was not involved, and material was not reviewed prior to publication.